MedCu Technologies Ltd. develops the world’s first FDA‑ and CE‑cleared wound dressings impregnated with copper microparticles, leveraging copper’s antibacterial properties to treat acute, postoperative and chronic wounds including diabetic foot, venous and arterial ulcers, burns and amputations.
| Website | http://www.medcu.com |
| Revenue | $1 million |
| Employees | 11 (8 on RocketReach) |
| Founded | 2017 |
| Industry | Medical Devices, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
| Keywords | Wound Care Solutions, Chronic Wound Management, Medical Device Technology, Infection Prevention, Medical Dressings, Surgical Wound Care, Burn Wound Treatment, Healthcare Technology |
| Competitors | Johnson & Johnson, Medtronic, Abbott, Stryker, BD, Cardinal Health, Boston Scientific, Zimmer Biomet, Teleflex, Smiths Medical +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular MedCu Technologies Ltd. employee's phone or email?
The MedCu Technologies Ltd. annual revenue was $1 million in 2026.
Danny Lustiger is the CEO and Founder of MedCu Technologies Ltd..
8 people are employed at MedCu Technologies Ltd..
The NAICS codes for MedCu Technologies Ltd. are [32541, 325, 32, 3254].
The SIC codes for MedCu Technologies Ltd. are [283, 28].